APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hib Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Hib Vaccine Market Outlook and Growth Opportunities 2026

22 December 2025197 pages

Choose your research edition.

Industry ResearchHib Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Hib Vaccine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Hib Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hib Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Hib Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Hib Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Hib Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hib Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hib Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Hib Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Hib Vaccine market include Lanzhou Institute, Zhifei Bio, Sanofi Pasteur, Kangtai Bio, Watson Bio, Glaxosmithkline, Olin Bio and Bharat Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hib Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hib Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hib Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hib Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Hib Vaccine Segment by Company

Lanzhou Institute

Zhifei Bio

Sanofi Pasteur

Kangtai Bio

Watson Bio

Glaxosmithkline

Olin Bio

Bharat Biotech

Hib Vaccine Segment by Type

Hib Vaccine

Multiple Seedlings

Hib Vaccine Segment by Application

Hospital

Clinic

Hib Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hib Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Hib Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hib Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Hib Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hib Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hib Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hib Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hib Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hib Vaccine industry.

Chapter 3: Detailed analysis of Hib Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Hib Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Hib Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hib Vaccine Industry Trends Table 2. Hib Vaccine Industry Drivers Table 3. Hib Vaccine Industry Opportunities and Challenges Table 4. Hib Vaccine Industry Restraints Table 5. Global Hib Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hib Vaccine Revenue Share by Company (2021-2026) Table 7. Global Hib Vaccine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Hib Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Hib Vaccine Average Price (US$/unit) of Company (2021-2026) Table 10. Global Hib Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Hib Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Hib Vaccine Company, Product Type & Application Table 13. Global Hib Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Hib Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Hib Vaccine Table 18. Significant Companies of Multiple Seedlings Table 19. Global Hib Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Hib Vaccine Sales Volume by Type (2021-2026) & (k units) Table 21. Global Hib Vaccine Sales Volume by Type (2027-2032) & (k units) Table 22. Global Hib Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Hib Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Hib Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Hib Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Hib Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Hib Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Hib Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global Hib Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Hib Vaccine Sales Volume by Application (2021-2026) & (k units) Table 33. Global Hib Vaccine Sales Volume by Application (2027-2032) & (k units) Table 34. Global Hib Vaccine Sales Volume Share by Application (2021-2026) Table 35. Global Hib Vaccine Sales Volume Share by Application (2027-2032) Table 36. Global Hib Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Hib Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Hib Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Hib Vaccine Sales Value Share by Application (2021-2026) Table 40. Global Hib Vaccine Sales Value Share by Application (2027-2032) Table 41. Global Hib Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Hib Vaccine Sales by Region (2021-2026) & (k units) Table 43. Global Hib Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Hib Vaccine Sales by Region (2027-2032) & (k units) Table 45. Global Hib Vaccine Sales Market Share by Region (2027-2032) Table 46. Global Hib Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Hib Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Hib Vaccine Sales Value Share by Region (2021-2026) Table 49. Global Hib Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Hib Vaccine Sales Value Share by Region (2027-2032) Table 51. Global Hib Vaccine Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Hib Vaccine Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Hib Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Hib Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Hib Vaccine Sales by Country (2021-2026) & (k units) Table 56. Global Hib Vaccine Sales Market Share by Country (2021-2026) Table 57. Global Hib Vaccine Sales by Country (2027-2032) & (k units) Table 58. Global Hib Vaccine Sales Market Share by Country (2027-2032) Table 59. Global Hib Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Hib Vaccine Sales Value Market Share by Country (2021-2026) Table 61. Global Hib Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Hib Vaccine Sales Value Market Share by Country (2027-2032) Table 63. Lanzhou Institute Company Information Table 64. Lanzhou Institute Business Overview Table 65. Lanzhou Institute Hib Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Lanzhou Institute Hib Vaccine Product Portfolio Table 67. Lanzhou Institute Recent Development Table 68. Zhifei Bio Company Information Table 69. Zhifei Bio Business Overview Table 70. Zhifei Bio Hib Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Zhifei Bio Hib Vaccine Product Portfolio Table 72. Zhifei Bio Recent Development Table 73. Sanofi Pasteur Company Information Table 74. Sanofi Pasteur Business Overview Table 75. Sanofi Pasteur Hib Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Sanofi Pasteur Hib Vaccine Product Portfolio Table 77. Sanofi Pasteur Recent Development Table 78. Kangtai Bio Company Information Table 79. Kangtai Bio Business Overview Table 80. Kangtai Bio Hib Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Kangtai Bio Hib Vaccine Product Portfolio Table 82. Kangtai Bio Recent Development Table 83. Watson Bio Company Information Table 84. Watson Bio Business Overview Table 85. Watson Bio Hib Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Watson Bio Hib Vaccine Product Portfolio Table 87. Watson Bio Recent Development Table 88. Glaxosmithkline Company Information Table 89. Glaxosmithkline Business Overview Table 90. Glaxosmithkline Hib Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Glaxosmithkline Hib Vaccine Product Portfolio Table 92. Glaxosmithkline Recent Development Table 93. Olin Bio Company Information Table 94. Olin Bio Business Overview Table 95. Olin Bio Hib Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Olin Bio Hib Vaccine Product Portfolio Table 97. Olin Bio Recent Development Table 98. Bharat Biotech Company Information Table 99. Bharat Biotech Business Overview Table 100. Bharat Biotech Hib Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Bharat Biotech Hib Vaccine Product Portfolio Table 102. Bharat Biotech Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Hib Vaccine Distributors List Table 106. Hib Vaccine Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Hib Vaccine Product Image Figure 2. Global Hib Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hib Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Hib Vaccine Sales (2021-2032) & (k units) Figure 5. Global Hib Vaccine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Hib Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Hib Vaccine Image Figure 10. Multiple Seedlings Image Figure 11. Global Hib Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Hib Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Hib Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Hib Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Hib Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Hib Vaccine Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Hib Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Hib Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Hib Vaccine Sales Volume Share by Application (2021-2032) Figure 22. Global Hib Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Hib Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Hib Vaccine Sales Value Share by Application (2021-2032) Figure 25. Global Hib Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Hib Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Hib Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Hib Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Hib Vaccine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Hib Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Hib Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Hib Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Hib Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Hib Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Hib Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Hib Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Hib Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Hib Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Hib Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Hib Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Hib Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Hib Vaccine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Hib Vaccine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Hib Vaccine
  • Multiple Seedlings
Applications
  • Hospital
  • Clinic
Companies covered
  • Lanzhou Institute
  • Zhifei Bio
  • Sanofi Pasteur
  • Kangtai Bio
  • Watson Bio
  • Glaxosmithkline
  • Olin Bio
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hib Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Hib Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Hib Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Hib Vaccine Market Dynamics
  1. 2.1 Hib Vaccine Industry Trends
  2. 2.2 Hib Vaccine Industry Drivers
  3. 2.3 Hib Vaccine Industry Opportunities and Challenges
  4. 2.4 Hib Vaccine Industry Restraints
3 Hib Vaccine Market by Company
  1. 3.1 Global Hib Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Hib Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Hib Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Hib Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Hib Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Hib Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Hib Vaccine Company Product Type and Application
  8. 3.8 Global Hib Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Hib Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Hib Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Hib Vaccine Market by Type
  1. 4.1 Hib Vaccine Type Introduction
  2. 4.1.1 Hib Vaccine
  3. 4.1.2 Multiple Seedlings
  4. 4.2 Global Hib Vaccine Sales Volume by Type
  5. 4.2.1 Global Hib Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hib Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Hib Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Hib Vaccine Sales Value by Type
  9. 4.3.1 Global Hib Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hib Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Hib Vaccine Sales Value Share by Type (2021-2032)
5 Hib Vaccine Market by Application
  1. 5.1 Hib Vaccine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Hib Vaccine Sales Volume by Application
  5. 5.2.1 Global Hib Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hib Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Hib Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Hib Vaccine Sales Value by Application
  9. 5.3.1 Global Hib Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hib Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Hib Vaccine Sales Value Share by Application (2021-2032)
6 Hib Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Hib Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hib Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Hib Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Hib Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Hib Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Hib Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Hib Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Hib Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Hib Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Hib Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Hib Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Hib Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Hib Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Hib Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Hib Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Hib Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Hib Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Hib Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Hib Vaccine Sales Value Share by Country, 2025 VS 2032
7 Hib Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Hib Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hib Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Hib Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Hib Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Hib Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Hib Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Hib Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Hib Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Hib Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Hib Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Hib Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Hib Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Hib Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Hib Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Hib Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Hib Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Hib Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Hib Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Hib Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Hib Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Hib Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Hib Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Hib Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Hib Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Hib Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Hib Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Hib Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Hib Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Hib Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Hib Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Hib Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Hib Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Hib Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Hib Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Hib Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Hib Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Hib Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Hib Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Hib Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lanzhou Institute
  2. 8.1.1 Lanzhou Institute Company Information
  3. 8.1.2 Lanzhou Institute Business Overview
  4. 8.1.3 Lanzhou Institute Hib Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Lanzhou Institute Hib Vaccine Product Portfolio
  6. 8.1.5 Lanzhou Institute Recent Developments
  7. 8.2 Zhifei Bio
  8. 8.2.1 Zhifei Bio Company Information
  9. 8.2.2 Zhifei Bio Business Overview
  10. 8.2.3 Zhifei Bio Hib Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zhifei Bio Hib Vaccine Product Portfolio
  12. 8.2.5 Zhifei Bio Recent Developments
  13. 8.3 Sanofi Pasteur
  14. 8.3.1 Sanofi Pasteur Company Information
  15. 8.3.2 Sanofi Pasteur Business Overview
  16. 8.3.3 Sanofi Pasteur Hib Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Pasteur Hib Vaccine Product Portfolio
  18. 8.3.5 Sanofi Pasteur Recent Developments
  19. 8.4 Kangtai Bio
  20. 8.4.1 Kangtai Bio Company Information
  21. 8.4.2 Kangtai Bio Business Overview
  22. 8.4.3 Kangtai Bio Hib Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Kangtai Bio Hib Vaccine Product Portfolio
  24. 8.4.5 Kangtai Bio Recent Developments
  25. 8.5 Watson Bio
  26. 8.5.1 Watson Bio Company Information
  27. 8.5.2 Watson Bio Business Overview
  28. 8.5.3 Watson Bio Hib Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Watson Bio Hib Vaccine Product Portfolio
  30. 8.5.5 Watson Bio Recent Developments
  31. 8.6 Glaxosmithkline
  32. 8.6.1 Glaxosmithkline Company Information
  33. 8.6.2 Glaxosmithkline Business Overview
  34. 8.6.3 Glaxosmithkline Hib Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Glaxosmithkline Hib Vaccine Product Portfolio
  36. 8.6.5 Glaxosmithkline Recent Developments
  37. 8.7 Olin Bio
  38. 8.7.1 Olin Bio Company Information
  39. 8.7.2 Olin Bio Business Overview
  40. 8.7.3 Olin Bio Hib Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Olin Bio Hib Vaccine Product Portfolio
  42. 8.7.5 Olin Bio Recent Developments
  43. 8.8 Bharat Biotech
  44. 8.8.1 Bharat Biotech Company Information
  45. 8.8.2 Bharat Biotech Business Overview
  46. 8.8.3 Bharat Biotech Hib Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bharat Biotech Hib Vaccine Product Portfolio
  48. 8.8.5 Bharat Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hib Vaccine Value Chain Analysis
  2. 9.1.1 Hib Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hib Vaccine Sales Mode & Process
  6. 9.2 Hib Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hib Vaccine Distributors
  9. 9.2.3 Hib Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst